EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanozyme Biosensors for Clinical and Wearable Diagnostics: Multimodal Signal Transduction, Diagnostic Confidence, and Translational Barriers

Muhammet Samet Kilic iD, Seyda Korkut Uru iD

The Chemical Record · 02.11.2026

DOI: 10.1002/tcr.70268 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Chemical Record, online erschienen am 02.11.2026. Verfasst von Muhammet Samet Kilic und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Zonguldak Bülent Ecevit University, Zonguldak, Türkiye. Die Arbeit nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanozyme‐based biosensors are emerging as artificial enzyme platforms for clinically significant and wearable diagnostic systems because they combine catalytic signal generation with structural robustness, tunable surface chemistry, and compatibility with miniaturized devices. This review specifically focuses on clinically oriented and wearable nanozyme biosensors. In this context, it addresses topics such as material design, biointerface engineering, signal transduction, multimodal validation, device integration, and validation‐not as independent performances but as an interconnected chain aimed at a single application. The primary contribution of this review is its emphasis on diagnostic reliability. This review also examines the major barriers limiting translation to clinical practice, including deficiencies in catalytic specificity, matrix interference, biological contamination, real‐sample variability, interbatch inconsistency, scalable production, biosafety, and regulatory readiness. In the study, multimodal, smartphone‐based, and AI‐assisted reading results were evaluated based on whether they enhance quantitative reliability, reduce interpretation uncertainty, and support clinically meaningful decisions. A goal‐oriented framework for transforming nanozyme biosensors from promising laboratory prototypes into clinically reliable, wearable, and digitally connected diagnostic technologies has been identified in the study.

Schlagwörter

Stichwörter der Autor:innen

biochipsclinical diagnosticsmicrofluidicsmultimodal sensingnanozymespoint‐of‐care testingwearable biosensors

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Zonguldak Bülent Ecevit University, Zonguldak, Türkiye.
  • Department of Environmental Engineering, Zonguldak Bülent Ecevit University, Zonguldak, Türkiye.

ORCID-Profile: Muhammet Samet Kilic, Seyda Korkut Uru

Zitieren

APA

Kilic, M. S., & Korkut Uru, S. (2026). Nanozyme Biosensors for Clinical and Wearable Diagnostics: Multimodal Signal Transduction, Diagnostic Confidence, and Translational Barriers. The Chemical Record. https://doi.org/10.1002/tcr.70268

Vancouver

Kilic MS, Korkut Uru S. Nanozyme Biosensors for Clinical and Wearable Diagnostics: Multimodal Signal Transduction, Diagnostic Confidence, and Translational Barriers. The Chemical Record. 2026. doi:10.1002/tcr.70268

BibTeX
@article{Kilic2026,
  author = {Kilic, Muhammet Samet and Korkut Uru, Seyda},
  title = {Nanozyme Biosensors for Clinical and Wearable Diagnostics: Multimodal Signal Transduction, Diagnostic Confidence, and Translational Barriers},
  journal = {The Chemical Record},
  year = {2026},
  doi = {10.1002/tcr.70268}
}
Kostenlos starten →